| Line item | Value |
|---|---|
| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | YoY | Trend | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current Assets | €2.6B | €2.7B | €2.8B | €3.0B | €2.7B | €2.2B | -0.9% | |
| Inventories | €62.0M | €79.0M | €84.0M | €79.0M | €65.0M | €68.0M | -21.5% | |
| Trade Receivables | €1.1B | €1.1B | €1.1B | €1.1B | €1.0B | €986.0M | -4.8% | |
| Non-Current Assets | €7.0B | €6.8B | €6.3B | €6.5B | €6.3B | €6.2B | +1.6% | |
| Cash & Equivalents | €932.0M | €954.0M | €1.1B | €1.3B | €1.0B | €723.0M | -2.3% | |
| Property, Plant & Equipment | €68.0M | €79.0M | €79.0M | €79.0M | €75.0M | €84.0M | -13.9% | |
| Goodwill | €4.8B | €4.7B | €4.3B | €4.4B | €4.2B | €4.0B | +1.6% | |
| Intangible Assets | €1.8B | €1.7B | €1.6B | €1.6B | €1.6B | €1.7B | +5.2% | |
| Deferred Tax Assets | €31.0M | €56.0M | €51.0M | €62.0M | €62.0M | €72.0M | -44.6% | |
| Total Assets | €9.6B | €9.5B | €9.1B | €9.5B | €9.0B | €8.3B | +0.9% | |
| Liabilities | ||||||||
| Current Liabilities | €4.1B | €3.8B | €3.8B | €3.9B | €3.1B | €3.2B | +7.2% | |
| Trade Payables | €1.1B | €1.1B | €997.0M | €990.0M | €944.0M | €819.0M | +2.9% | |
| Non-Current Liabilities | €4.7B | €4.2B | €3.6B | €3.3B | €3.6B | €3.1B | +13.4% | |
| Deferred Tax Liabilities | €328.0M | €324.0M | €281.0M | €299.0M | €294.0M | €305.0M | +1.2% | |
| Total Liabilities | €8.8B | €8.0B | €7.3B | €7.2B | €6.6B | €6.3B | +10.5% | |
| Equity | ||||||||
| Share Capital | €28.0M | €29.0M | €30.0M | €31.0M | €32.0M | €32.0M | -3.4% | |
| Share Premium | €87.0M | €87.0M | €87.0M | €87.0M | €87.0M | €87.0M | +0.0% | |
| Retained Earnings | €1.2B | €1.4B | €2.0B | €2.5B | €2.3B | €2.3B | -13.8% | |
| Minority Interests | €0 | €0 | €0 | €0 | €0 | €0 | — | |
| Total Equity | €798.0M | €1.5B | €1.7B | €2.3B | €2.4B | €2.1B | -48.3% | |
New to Ticker
Create a free Ticker account to see every line of the income statement, balance sheet and cash flow, plus dividends and financial health.
Sign up freeAlready have an account? Sign in
Already a member
Welcome back
Sign in to pick up where you left off, with full access to every page.
Sign in